top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-Luc Hep 3B plus
Common name
B-Luc Hep 3B plus Catalog number   310678
Aliases NA  Disease Hepatocellular carcinoma
Organism
Human 
Strain NA
Tissue types Liver Tissue Liver

Description

This B-Luc Hep 3B plus cell line expresses firefly luciferase as a marker of Hep 3B cells. Luminescence can be observed in B-Luc Hep 3B plus cells.


Application


B-Luc Hep 3B plus cell line can be used to evaluate anti-cancer drugs in hepatocellular carcinoma in vivo.


Targeting strategy

Gene targeting strategy for B-Luc Hep 3B plus cells. The exogenous promoter and luciferase were inserted into the AAVS1 locus in B-Luc Hep 3B plus.


In vitro luciferase activity of B-Luc Hep 3B plus cells


from clipboard


Luminescence signal intensity of B-Luc Hep 3B plus cells. Luminescence intensity was measured using the Bright-GloTM luciferase Assay (Promega, Cat E2610). B-Luc Hep 3B plus cells have a strong luminescence signal. The 1-A06 clone of B-Luc Hep 3B plus cells can be used in vivo experiments.

Tumor growth curve & Body weight changes


from clipboard


Subcutaneous homograft tumor growth of B-Luc Hep 3B plus cells. B-Luc Hep 3B plus cells (8x106 ) and wild-type Hep 3B cells (8x106) were subcutaneously implanted into b-NDG mice (female, 5-week-old, n=4). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-Luc Hep 3B plus cells were able to establish tumors in vivo and can be used for efficacy studies.

Quantitative imaging data & body weight changes


from clipboard

Tumor growth and in vivo imaging of B-Luc Hep 3B plus cells. B-Luc Hep 3B plus cells (8x106) were subcutaneously implanted into the wild-type B-NDG mice. Signal intensity and body weight were measured twice a week. (A) Imaging was performed twice a week. (B) Body weight (Mean ± SEM). B-Luc Hep 3B plus cells can be used for in vivo efficacy evaluation.